Across TCGA pan-cancer cohorts, RPL37P10 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RPL37P10 data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RPL37P10 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated RPL37P10 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.
BLCA, SKCM, and LIHC are the cancer types where RPL37P10 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.